Posted by Michael Wonder on 04 Mar 2026
FDA approves first generic of Flovent HFA for treatment of asthma
3 March 2026 - Today, the US FDA approved the first generic of Flovent HFA (fluticasone propionate) inhalation aerosol, 44 mcg/actuation, for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older.
The FDA granted approval of fluticasone propionate inhalation aerosol to Glenmark Specialty.
